ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) Shares Down 0.1%

ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) fell 0.1% during trading on Wednesday . The stock traded as low as $14.30 and last traded at $14.41, 1,168 shares traded hands during trading. A decline of 92% from the average session volume of 14,970 shares. The stock had previously closed at $14.42.

The firm’s 50 day simple moving average is $15.12 and its 200 day simple moving average is $14.68.

A hedge fund recently bought a new stake in ProShares UltraPro Short Nasdaq Biotechnology stock. Susquehanna International Group LLP bought a new position in shares of ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 10,082 shares of the company’s stock, valued at approximately $136,000. Susquehanna International Group LLP owned about 4.03% of ProShares UltraPro Short Nasdaq Biotechnology at the end of the most recent quarter.

Featured Story: How to invest in blue-chip stocks

Receive News & Ratings for ProShares UltraPro Short Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraPro Short Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.